{"id":"https://openalex.org/W2546719313","doi":"https://doi.org/10.1158/2326-6066.imm2016-ia08","title":"Abstract IA08: Identifying and overcoming metabolic checkpoints to antitumor immunity","display_name":"Abstract IA08: Identifying and overcoming metabolic checkpoints to antitumor immunity","publication_year":2016,"publication_date":"2016-10-31","ids":{"openalex":"https://openalex.org/W2546719313","doi":"https://doi.org/10.1158/2326-6066.imm2016-ia08","mag":"2546719313"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.imm2016-ia08","doi":"https://doi.org/10.1158/2326-6066.imm2016-ia08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.imm2016-ia08","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088178087","display_name":"Greg M. Delgoffe","orcid":"https://orcid.org/0000-0002-2957-8135","observed_orcids":["https://orcid.org/0000-0002-2957-8135"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Greg M. Delgoffe","raw_affiliation_strings":["University of Pittsburgh Cancer Institute, Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh Cancer Institute, Pittsburgh, PA","institution_ids":["https://openalex.org/I4210128526"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5088178087"],"corresponding_institution_ids":["https://openalex.org/I4210128526"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"4","issue":"11_Supplement","first_page":"IA08","last_page":"IA08"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6542999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6542999744415283,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10631","display_name":"Cancer, Hypoxia, and Metabolism","score":0.20909999310970306,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.032499998807907104,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-microenvironment-metabolism","display_name":"tumor microenvironment metabolism","score":0.7910000085830688},{"id":"https://openalex.org/keywords/t-cell-metabolic-reprogramming","display_name":"T cell metabolic reprogramming","score":0.7129999995231628},{"id":"https://openalex.org/keywords/mitochondrial-dysfunction","display_name":"mitochondrial dysfunction","score":0.8479999899864197},{"id":"https://openalex.org/keywords/pgc-1alpha","display_name":"PGC-1\u03b1","score":0.8500000238418579},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.7419999837875366},{"id":"https://openalex.org/keywords/foxo","display_name":"FOXO","score":0.8859999775886536},{"id":"https://openalex.org/keywords/immunotherapy-resistance","display_name":"immunotherapy resistance","score":0.7110000252723694},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8090000152587891},{"id":"https://openalex.org/keywords/tumor-hypoxia","display_name":"tumor hypoxia","score":0.847000002861023},{"id":"https://openalex.org/keywords/glucose-uptake","display_name":"glucose uptake","score":0.3230000138282776}],"concepts":[{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.7527575492858887},{"id":"https://openalex.org/C2777229759","wikidata":"https://www.wikidata.org/wiki/Q6881848","display_name":"Mitochondrial biogenesis","level":3,"score":0.6581624150276184},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5154581665992737},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49733975529670715},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48162978887557983},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.47759413719177246},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4345243275165558},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.42684975266456604},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.42524439096450806},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.42155903577804565},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4182833433151245},{"id":"https://openalex.org/C28859421","wikidata":"https://www.wikidata.org/wiki/Q39572","display_name":"Mitochondrion","level":2,"score":0.4017561376094818},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.331948459148407},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3254740834236145},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10833615064620972},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.imm2016-ia08","doi":"https://doi.org/10.1158/2326-6066.imm2016-ia08","is_oa":false,"landing_page_url":"https://doi.org/10.1158/2326-6066.imm2016-ia08","pdf_url":null,"source":{"id":"https://openalex.org/S2765010658","display_name":"Cancer Immunology Research","issn_l":"2326-6066","issn":["2326-6066","2326-6074"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-2","ki-jl-2","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6200000047683716}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4200022043","https://openalex.org/W2112727616","https://openalex.org/W4296613612","https://openalex.org/W2884525857","https://openalex.org/W4322720888","https://openalex.org/W3193904228","https://openalex.org/W3111580887","https://openalex.org/W2902626376","https://openalex.org/W3185708072","https://openalex.org/W2893846263"],"abstract_inverted_index":{"Abstract":[0],"It":[1],"has":[2],"now":[3],"become":[4],"clear":[5],"that":[6,142,170,214,296,324,343],"the":[7,34,64,105,121,124,179,184,193,207,325,329,350,360,382],"immune":[8],"system":[9],"is":[10,20,33,176,202],"not":[11,322],"oblivious":[12],"to":[13,63,101,118,131,137,178,206,243,282,339,358,375],"cancer":[14,68],"initiation":[15],"and":[16,52,76,81,88,98,112,134,147,161,187,200,225,259,262,315,371],"progression,":[17],"but":[18,342],"rather":[19],"rendered":[21],"dysfunctional":[22],"through":[23,304],"a":[24,37,77,129,151,162,211,230,267,274,336],"wide":[25],"array":[26],"of":[27,31,36,45,49,54,67,79,108,123,153,165,173,197,209,233,239,299,306,328,335,346,363,381],"tolerogenic":[28],"mechanisms.":[29],"One":[30],"these":[32],"generation":[35],"potently":[38],"immunosuppressive":[39],"microenvironment,":[40,186],"characterized":[41,156,253],"by":[42,157,254],"altered":[43,71],"populations":[44],"suppressive":[46,50],"cells,":[47,69],"secretion":[48],"cytokines,":[51],"upregulation":[53],"inhibitory":[55],"ligands.":[56],"The":[57],"tumor":[58,125,185,260,307,330],"microenvironment":[59,126,331,351],"also":[60],"possesses,":[61],"due":[62],"deregulated":[65],"energetics":[66],"an":[70,355],"metabolic":[72,154,237,326,344,373],"profile:":[73],"hypoxia,":[74],"acidosis,":[75],"dearth":[78],"glucose":[80,96,159],"other":[82],"carbon":[83],"sources.":[84],"T":[85,143,241,300,347],"cell":[86,301,317],"activation":[87,181,224],"effector":[89],"function":[90,175],"are":[91,289],"metabolically":[92],"demanding,":[93],"requiring":[94],"elevated":[95],"processing":[97],"mitochondrial":[99,166,198,216,245,271,302],"activity":[100,199,303],"keep":[102],"up":[103],"with":[104],"bioenergetic":[106],"demands":[107],"proliferation,":[109,256],"cytokine":[110,257],"secretion,":[111],"cytolytic":[113],"capacity.":[114],"Thus,":[115],"we":[116,219],"sought":[117],"determine":[119],"whether":[120],"metabolism":[122],"acts":[127],"as":[128,229],"barrier":[130],"antitumor":[132,251,278,376],"immunity":[133,279,377],"resistance":[135],"mechanism":[136],"immunotherapy.":[138],"We":[139,168],"have":[140,220],"demonstrated":[141],"cells":[144,242,348],"infiltrating":[145],"murine":[146],"human":[148],"tumors":[149],"exhibit":[150],"phenotype":[152],"insufficiency,":[155],"decreased":[158],"uptake":[160],"crippling":[163],"loss":[164,172,196],"function.":[167],"show":[169],"this":[171,287],"oxidative":[174],"specific":[177],"chronic":[180,222],"observed":[182],"in":[183,204,248,269,280],"occurs":[188],"rapidly":[189],"upon":[190],"entry":[191],"into":[192,391],"tumor.":[194],"This":[195],"mass":[201],"due,":[203],"part,":[205],"repression":[208],"PGC1\u03b1,":[210],"transcriptional":[212],"co-activator":[213],"programs":[215],"biogenesis.":[217],"Further,":[218],"identified":[221],"Akt":[223],"consequent":[226],"Foxo":[227],"inactivation":[228],"major":[231],"driver":[232],"PGC1\u03b1":[234],"repression.":[235],"Importantly,":[236],"reprogramming":[238,345],"tumor-specific":[240],"enforce":[244],"biogenesis":[246],"results":[247],"dramatically":[249,309],"increased":[250],"immunity,":[252],"robust":[255],"production,":[258],"regression":[261],"clearance.":[263],"Our":[264,319],"data":[265,320],"support":[266],"model":[268],"which":[270],"insufficiency":[272],"represents":[273],"primordial":[275],"checkpoint":[276,313],"inhibiting":[277],"addition":[281],"immunologic":[283],"suppression.":[284],"Further":[285],"supporting":[286],"notion":[288],"additional":[290],"studies":[291],"from":[292],"our":[293],"laboratory":[294],"suggesting":[295],"selective":[297],"boosting":[298],"mitigation":[305],"hypoxia":[308],"enhances":[310],"immunotherapies":[311],"like":[312],"blockade":[314],"adoptive":[316],"therapy.":[318],"suggest":[321],"only":[323],"nature":[327],"may":[332,353],"be":[333,354],"predictive":[334],"patient's":[337],"response":[338],"various":[340],"immunotherapies,":[341],"or":[349],"itself":[352],"important":[356],"means":[357],"improve":[359],"immunotherapeutic":[361],"treatment":[362],"cancer.":[364],"Citation":[365],"Format:":[366],"Greg":[367],"M.":[368],"Delgoffe.":[369],"Identifying":[370],"overcoming":[372],"checkpoints":[374],"[abstract].":[378],"In:":[379],"Proceedings":[380],"Second":[383],"CRI-CIMT-EATI-AACR":[384],"International":[385],"Cancer":[386,402],"Immunotherapy":[387],"Conference:":[388],"Translating":[389],"Science":[390],"Survival;":[392],"2016":[393],"Sept":[394],"25-28;":[395],"New":[396],"York,":[397],"NY.":[398],"Philadelphia":[399],"(PA):":[400],"AACR;":[401],"Immunol":[403],"Res":[404],"2016;4(11":[405],"Suppl):Abstract":[406],"nr":[407],"IA08.":[408]},"counts_by_year":[],"updated_date":"2026-07-14T23:27:15.235271","created_date":"2025-10-10T00:00:00"}